71 related articles for article (PubMed ID: 4456497)
21. Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors.
Auclair A; Blanc G; Glowinski J; Tassin JP
J Neurochem; 2004 Oct; 91(2):318-26. PubMed ID: 15447665
[TBL] [Abstract][Full Text] [Related]
22. Radioenzymatic paper-chromatographic assay for dopamine and norepinephrine in cerebroventricular cisternal perfusate of cat following administration of cocaine or d-amphetamine.
Chiueh CC; Kopin IJ
J Neurochem; 1978 Aug; 31(2):561-4. PubMed ID: 671057
[No Abstract] [Full Text] [Related]
23. Amantadine enhances dopamine and serotonin turnover in the MPTP model of Parkinson's disease.
Altagracia M; Rojas P; Kravzov J; Rios C
Proc West Pharmacol Soc; 1993; 36():289-91. PubMed ID: 7690973
[No Abstract] [Full Text] [Related]
24. Metabolism of 3H-dopamine continuously perfused through push-pull cannulas in rats' brains: modification by amphetamine or prostaglandin F2 alpha.
Nielsen JA; Fossom LH; Sparber SB
Pharmacol Biochem Behav; 1980 Aug; 13(2):235-42. PubMed ID: 7413695
[TBL] [Abstract][Full Text] [Related]
25. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
Robbins TW; Roberts DC; Koob GF
J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
[TBL] [Abstract][Full Text] [Related]
26. Responses of neurones in the cerebral cortex and caudate nucleus to amantadine, amphetamine and dopamine.
Stone TW
Br J Pharmacol; 1976 Jan; 56(1):101-10. PubMed ID: 1252658
[TBL] [Abstract][Full Text] [Related]
27. The effect of dopamine uptake blocking agents on the amphetamine-induced circling behavior in mice with unilateral nigro-striatal lesions.
Fung YK; Uretsky NJ
J Pharmacol Exp Ther; 1980 Sep; 214(3):651-6. PubMed ID: 6772760
[TBL] [Abstract][Full Text] [Related]
28. Temperature responses to intraventricular amphetamine in unanesthetized cats.
Terwelp DR; Kennedy MS; Burks TF
Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):795-804. PubMed ID: 4760888
[No Abstract] [Full Text] [Related]
29. Alterations in dopaminergic function after subacute ethanol administration.
Mullin MJ; Ferko AP
J Pharmacol Exp Ther; 1983 Jun; 225(3):694-8. PubMed ID: 6864527
[TBL] [Abstract][Full Text] [Related]
30. Dopamine: spontaneous and drug-induced release from the caudate nucleus in the cat.
Besson M; Cheramy A; Feltz P; Glowinski J
Brain Res; 1971 Sep; 32(2):407-24. PubMed ID: 4400012
[No Abstract] [Full Text] [Related]
31. 5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants.
Auclair A; Drouin C; Cotecchia S; Glowinski J; Tassin JP
Eur J Neurosci; 2004 Dec; 20(11):3073-84. PubMed ID: 15579162
[TBL] [Abstract][Full Text] [Related]
32. Further studies on the mode of action of amantadine.
Strömberg U; Svensson TH
Acta Pharmacol Toxicol (Copenh); 1971; 30(3):161-71. PubMed ID: 5171936
[No Abstract] [Full Text] [Related]
33. Effect of amantadine on cerebral acetylcholine release and content in the guinea pig.
Beani L; Bianchi C
Neuropharmacology; 1973 Apr; 12(4):283-9. PubMed ID: 4703874
[No Abstract] [Full Text] [Related]
34. Amantadine decreases d-amphetamine stimulation and increases d-amphetamine anorexia in mice.
Clark R; Smith DH; Vernier VG; Rubin AA
Proc Soc Exp Biol Med; 1976 Feb; 151(2):434-6. PubMed ID: 1061960
[TBL] [Abstract][Full Text] [Related]
35. On the mode of action of amantadine.
Stromberg U; Svensson TH; Waldeck B
J Pharm Pharmacol; 1970 Dec; 22(12):959-62. PubMed ID: 4395528
[No Abstract] [Full Text] [Related]
36. Drugs acting through dopamine release.
Carlsson A
Pharmacol Ther B; 1975; 1(3):401-5. PubMed ID: 772710
[No Abstract] [Full Text] [Related]
37. Effect of reserpine on accumulation and removal of d-amphetamine- 3 H.
Stolk JM; Rech RH
Biochem Pharmacol; 1969 Oct; 18(10):2786-8. PubMed ID: 5404008
[No Abstract] [Full Text] [Related]
38. Blockade of the central effects of d-amphetamine sulfate by amantadine hydrochloride.
Menon MK; Clark WG; Fleming RM
Eur J Pharmacol; 1973 Mar; 21(3):311-7. PubMed ID: 4708069
[No Abstract] [Full Text] [Related]
39. Effects of amantadine on uptake and release of dopamine by a particulate fraction of rat basal ganglia.
Heimans RL; Rand MJ; Fennessy MR
J Pharm Pharmacol; 1972 Nov; 24(11):875-9. PubMed ID: 4405650
[No Abstract] [Full Text] [Related]
40. Metabolic fate of amphetamine in the cat during development of tolerance.
Ellison T; Okun R; Silverman A; Siegel M
Arch Int Pharmacodyn Ther; 1971 Mar; 190(1):135-49. PubMed ID: 5551196
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
